Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease

NCT: NCT06744543 · ACTIVE_NOT_RECRUITING

NCT IDNCT06744543
StatusACTIVE_NOT_RECRUITING
Start Date2025-03-12
Completion2027-02-01
SponsorVanderbilt University Medical Center (OTHER)
First posted
Last updated

Brief Summary

This study will evaluate the effectiveness of SIGHT as a clinical support system to prompt provider/patient discussion and shared decision making regarding the need for genetic testing in the form of a chromosomal microarray. Identifying patients at high predicted probability of needing a test in clinical settings will be examined to determine if it decreases the duration of time to testing and increases diagnostic yield. SIGHT requires only data already collected in routine clinical encounters and is calculated prior to a clinical visit at VUMC.

Frequently Asked Questions

What is Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease?

Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease is a clinical trial registered under NCT06744543. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06744543?

The current status of NCT06744543 (Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease) is: ACTIVE_NOT_RECRUITING.

When did Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease start?

Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease started on 2025-03-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑